Deutsche Bank Ag\ Cogent Biosciences, Inc. Transaction History

Deutsche Bank Ag\

$245 Billion
Q1 2025

A detailed history of Deutsche Bank Ag\ transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 70,897 shares of COGT stock, worth $523,219. This represents 0.0% of its overall portfolio holdings.

Number of Shares

70,897

Previous 79,265 10.56%

Holding current value

$523,219

Previous $618,000 31.39%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$5.99 - $9.66 $50,124 - $80,834	-8,368 Reduced 10.56%	70,897 $424,000
Q4 2024 Feb 14, 2025	SELL	$7.64 - $12.28 $638,650 - $1.03 Million	-83,593 Reduced 51.33%	79,265 $618,000
Q3 2024 Jun 26, 2025	BUY	$8.24 - $11.48 $757,758 - $1.06 Million	91,961 Added 129.71%	162,858 $1.76 Million
Q3 2024 Nov 13, 2024	SELL	$8.24 - $11.48 $622,795 - $867,681	-75,582 Reduced 31.7%	162,858 $1.76 Million
Q2 2024 Jun 12, 2025	BUY	$6.01 - $9.04 $1.01 Million - $1.51 Million	167,543 Added 236.32%	238,440 $2.01 Million
Q2 2024 Aug 14, 2024	SELL	$6.01 - $9.04 $2,920 - $4,393	-486 Reduced 0.2%	238,440 $2.01 Million
Q1 2024 Jun 02, 2025	BUY	$4.38 - $9.02 $735,967 - $1.52 Million	168,029 Added 237.0%	238,926 $1.61 Million
Q1 2024 May 15, 2024	BUY	$4.38 - $9.02 $882,530 - $1.82 Million	201,491 Added 538.24%	238,926 $1.61 Million
Q4 2023 Feb 14, 2024	SELL	$4.06 - $10.08 $2,431 - $6,037	-599 Reduced 1.57%	37,435 $220,000
Q3 2023 Nov 09, 2023	BUY	$9.69 - $13.34 $88,237 - $121,474	9,106 Added 31.48%	38,034 $370,000
Q2 2023 Aug 14, 2023	SELL	$9.85 - $13.24 $147,464 - $198,216	-14,971 Reduced 34.1%	28,928 $342,000
Q1 2023 May 15, 2023	BUY	$10.04 - $15.5 $86,625 - $133,734	8,628 Added 24.46%	43,899 $473,000
Q4 2022 Feb 13, 2023	BUY	$10.65 - $14.84 $90,056 - $125,487	8,456 Added 31.53%	35,271 $407,000
Q3 2022 Nov 14, 2022	BUY	$9.39 - $16.99 $53,757 - $97,267	5,725 Added 27.15%	26,815 $400,000
Q2 2022 Aug 11, 2022	BUY	$3.92 - $9.73 $3,578 - $8,883	913 Added 4.52%	21,090 $190,000
Q1 2022 May 13, 2022	SELL	$5.31 - $8.7 $12,733 - $20,862	-2,398 Reduced 10.62%	20,177 $151,000
Q4 2021 Feb 11, 2022	BUY	$7.51 - $10.81 $9,027 - $12,993	1,202 Added 5.62%	22,575 $194,000
Q3 2021 Nov 04, 2021	SELL	$5.99 - $9.14 $4,115 - $6,279	-687 Reduced 3.11%	21,373 $180,000
Q2 2021 Aug 11, 2021	BUY	$7.82 - $9.3 $172,509 - $205,158	22,060 New	22,060 $179,000

Others Institutions Holding COGT

# of Institutions

196

Shares Held

116M

Call Options Held

61.9K

Put Options Held

223K

View Full List

About Cogent Biosciences, Inc.

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $485M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

More about COGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account